Luc Besson, the French filmmaker behind "The Fifth Element" and "Lucy," confirmed he's developing a new science fiction project while speaking at the Venice Film Festival. The director promised the work will be audacious and demanding for audiences, joking that viewers might require both a theater ticket and aspirin to survive the experience.

"It's going to be crazy, believe me," Besson said during a masterclass at Venice. "Maybe you will need a ticket and an aspirin at the same time. I'm older, so I'm trying to explore everything now." The comment reflects both his signature maximalist sensibility and his stated desire to push boundaries as he enters the later phase of his career.

Besson returns to science fiction after decades of genre-hopping. His 1985 directorial debut "Subway" contained speculative elements, but "The Fifth Element" (1997) remains his most celebrated work in the space opera subgenre, featuring Bruce Willis, Milla Jovovich, and elaborate world-building that influenced blockbuster sci-fi for years. He revisited the territory with "Lucy" (2014), a time-bending thriller about psychic enhancement. Between those bookends, Besson moved through action ("Léon: The Professional"), fantasy ("Joan of Arc"), and crime drama ("The Family").

The announcement carries weight in an industry where aging auteurs often retreat from ambitious projects. Besson's statement suggests the opposite impulse. At an age when many directors consolidate their legacies or chase safer commercial formulas, he's plotting elaborate universes that will challenge audiences. This aligns with his career trajectory. He's never been a minimalist. His films demand scale, technical innovation, and viewer endurance.

His presence at Venice also included praise for Madonna, whom he called "a phenomenon." The comment emerged during panel discussion, positioning the pop icon alongside other cultural forces that Besson views as transformative. The remark fits his tendency to blur lines between high art and popular culture. He's always championed the spectacle, the visceral, the theatrical.

What matters here is tone. Besson isn't talking about a streamlined indie project or a quiet character study. He's warning audiences. The aspirin comment reads as a promise and a threat. The new film will be visually overwhelming, conceptually dense, probably loud, almost certainly expensive. It reflects a particular confidence: that audiences still crave immersion from filmmakers willing to take risks.

The development sits within a broader industry moment. Streaming platforms have fragmented theatrical attention. Audiences trained on shorter content struggle with three-hour experiences. Yet filmmakers like Denis Villeneuve have proven that scale still works if the story justifies it. Besson's new sci-fi project enters this landscape as a statement of faith in the theatrical medium.

No release date, title, or studio attachment has been announced. Production details remain sparse. But the masterclass comment itself matters. Besson was announcing intention. He was telling the industry, investors, and audiences that another Besson sci-fi experience is coming. The warning about aspirins suggests it won't be digestible. It will be uncompromising.